Yes, it is perfectly normal
Very early in vivo research on pharmacokinetics indicates the possibility that body protection compound 157 (BPC-157) is at the forefront of therapeutic peptides, with early demonstrations of View Full Study BPC 157 Therapy: Targeting Angiogenesis and Nitric Oxide's Cytotoxic and Damaging Actions, but Maintaining, Promoting, or Recovering Their Essential Protective Functions
Disclaimer: This content is for educational purposes only and does not constitute medical advice
However, individual timelines vary based on dosage protocol, the severity of the condition being treated, the quality of the peptide product used, and whether the therapy is administered under medical supervision
Semax has been used or authorized in other countries, but international status does not establish U.S